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Staphylococcus aureus infections induce formation of neutrophil-rich abscesses filled with debris from dead
phagocytes. Corbin and colleagues report that this pus has antimicrobial powers through the activity of cal-
protectin. Calprotectin, a member of the S100 family of proinflammatory proteins, acts through chelation of
manganese. As manganese is an essential cofactor for several enzymes in S. aureus, this impacts bacterial
growth and the bacterium’s ability to withstand oxidative stress.Staphylococcus aureus is a ubiquitous
bacterium that is generating increasingly
bad press coverage due to its propensity
to adopt a pathogenic lifestyle in hospital
and community settings. It colonizes the
skin readily and can lead to a wide range
of pathological conditions from, skin
lesions to osteomyelitis, endocarditis,
and septicemia. Drug resistance among
Staphylococcus isolates amplifies this
escalating problem (de Lencastre et al.,
2007). In the 1960s, penicillin-resistant
strains started to emerge. These are
known as methicillin-resistant S. aureus
(MRSA) and were found to show broad-
spectrum resistance to all b-lactam antibi-
otics. MRSA have now given rise to multi-
drug-resistant strains that are impervious
to macrolides, tetracyclines, and genta-
mycin. The presence of these new gener-
ations of MRSA in healthcare facilities is
a serious concern globally.
Understanding the transition from com-
mensalism to theadoptionof apathogenic
lifestyle requires an appreciation of both
the opportunities that a commensal bac-
terium may seek to exploit, and the ‘‘fail-
ure’’ of human defense mechanisms to
deny the bacterium these opportunities.
The elegant paper by Corbin and col-
leagues, published in a recent issue of
Science, highlights this transition by eluci-
dating the crosstalk between bacterial
physiology and the innate defense mech-
anisms of the host (Corbin et al., 2008).
One of the pathological consequences
of an S. aureus infection is the develop-
ment of skin abscesses characterized by
the extensive recruitment of neutrophils.
Neutrophils are the front-guard in re-
sponse to bacterial invasion and are
equipped with an arsenal of antimicrobial
agents. They generate a robust superox-ide response, contain a range of antimi-
crobial peptides, and can degranulate to
release a toxic mix of hydrolases. A horde
of angry neutrophils is usually damaging
to both pathogen and host, and this ex-
treme reaction is, of necessity, transient
in nature. It is regulated by the developing
acquired immune response, which com-
bats the infection and limits tissue dam-
age. Any pathogen capable of surviving
this frontal assault will be met by a less
frenetic, but more focused attack medi-
ated by antibodies, lymphocytes, and
macrophages.
Corbin and colleagues have made
some observations key to our under-
standing of the mode of action of the neu-
trophil-derived, antibacterial protein cal-
protectin (Corbin et al., 2008). Their data
stress the importance of this protein in
restricting bacterial replication within the
infected lesion. Calprotectin is a hetero-
dimer known by several different names:
S100A8/S100A9, MRP8/14, calgranulin
A/B, and 27E10 antigen (Striz and Trebi-
chavsky, 2004; Yui et al., 2003). It is an
EF-hand, Ca2+-binding protein that ac-
counts for a staggering 40% of the total
cytoplasmic protein concentration of neu-
trophils. It is known for its ability to inhibit
the growth of a broad range of microbes,
including both fungi and bacteria, and
was thought to function through the
chelation and sequestration of Zn2+. The
authors confirmed that calprotectin sup-
pressed growth of S. aureus through the
chelation of an essential component in
themedia; however, they went on to dem-
onstrate that it was Mn2+, rather than
Zn2+, that rescued the bacteria from
growth limitation.
Manganese is a particularly intriguing
target because, in addition to being anCell Host & Micessential cofactor for catalases, superox-
ide dismutases, and peroxidases, Mn(II) is
also capable of acting catalytically to
scavenge superoxide and hydrogen
peroxide (Horsburgh et al., 2002b). The
authors confirmed the central role of
Mn2+ in limiting bacterial growth through
the demonstration that S. aureusmutants
lacking in Mn2+ transport (mntA and
mntB) showed increased sensitivity to
calprotectin, while mutants that suffered
from Mn toxicity because they were un-
able to regulate Mn2+ transport (mntR)
were protected by calprotectin. Following
phagocytosis of the cocci, neutrophils
from wild-type and calprotectin-deficient
mice were able to kill S. aureus equally
well. However, cytoplasmic extracts
from human neutrophils inhibited bacte-
rial growth, and this activity was reversed
by either immunodepletion of calprotectin
or addition of excess Mn2+. As neutrophil-
rich lesions, such as the S. aureus
abscesses, exhibit massive cell death of
recruited phagocytes, it is not difficult to
see how this protein could accumulate
at the site of infection and act as a sink
for available Mn2+.
So, what are the consequences of cal-
protectin activity and Mn2+ depletion?
This is where I believe it gets even more
interesting and promises to be a fertile
area for future research. In S. aureus, in
addition to the need forMn2+ as a nutrient,
Mn2+ homeostasis is intimately interwo-
ven with regulation of iron availability
and the defense against oxidative stress
(Horsburgh et al., 2002b), diagrammed in
Figure 1.MntR encodes a Diphtheria toxin
repressor (DtxR)-like protein that controls
expression of the MntABC and MntH
Mn2+ transport systems (Ando et al.,
2003; Horsburgh et al., 2002a). Mutationsrobe 3, March 2008 ª2008 Elsevier Inc. 115
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PreviewsFigure 1. Neutrophils Are Recruited to the Site of Infection, Where Many of the Cells Die
through Programmed Cell Death and Necrosis
Death of the neutrophils releases calprotectin, which is abundant in the cytosol of these phagocytes.
Calprotectin acts to chelate manganese from the surrounding environment. The reduction of the concen-
tration of available manganese diminishes the viability of Staphylococcus aureus through a variety of
possible routes linked to nutrition and the capability of the bacterium to mount an effective response to
the reactive oxygen species generated by the neutrophils.in mntABC were reported to increase the
sensitivity of the bacteria to reactive oxy-
gen species (ROS), a phenotype that can
be rescued by addition of Mn2+ (Hors-
burgh et al., 2002a). PerR, the peroxide
resistance regulon repressor, is a Mn2+-
dependent, peroxidase-sensitive regula-
tor that modulates mntABC expression,
along with the expression of katA (cata-
lase), ftn (ferritin), and fur (ferric uptake
regulator) (Horsburgh et al., 2002b; Mor-
rissey et al., 2004). This cascade suggests
that chelation of Mn2+ by calprotectin will
impact S. aureus survival through denying
the bacterium an essential cofactor, while
rendering it potentially more susceptible
to the reactive oxygen intermediates
released by the neutrophils. This suscep-
tibility may be mediated through multiple
routes, such as inhibition of Mn2+-depen-
dent superoxide dismutase activity (Kara-
volos et al., 2003), and absence of Mn(II)-
mediated scavenging of superoxide and
hydrogen peroxide (Horsburgh et al.,
2002a). The reduced availability of Mn2+116 Cell Host & Microbe 3, March 2008 ª20may also diminish PerR activity, upregu-
lating expression of Fur, which should
lead to decreased iron transport and in-
creased expression of catalase and ferri-
tin (Horsburgh et al., 2001). In theory,
this should lead to a decreased suscepti-
bility to ROS; however, this is predomi-
nantly the route of avoiding damage
mediated by H202, which won’t be gener-
ated in the absence of superoxide dis-
mutase. Additional studies are clearly
needed to determine by which route(s)
the depletion of Mn2+mediated by calpro-
tectin may impact the bacterium’s resis-
tance to oxidative stress generated by
the neutrophil’s membrane-associated
NADPH oxidase complex.
Finally, Paclet and colleagues recently
reported that the NADPH oxidase com-
plex isolated from B cells showed a lower
constitutive turnover rate of O2
 produc-
tion than the oxidase complex isolated
from neutrophils (Paclet et al., 2007).
Upon analysis they determined that the
conformation of the NADPH oxidase-08 Elsevier Inc.associated membrane cytochrome b558
from neutrophils was in an ‘‘open’’ state
that enhanced the activity of the complex.
The addition of the calprotectin dimer to
purified NADPH oxidase from B cells
altered the conformation of cytochrome
b558 and enhanced the output of O2
.
This indicates that calprotectin may en-
hance killing both by rendering the patho-
gen more susceptible and by enhancing
the output of ROS from the neutrophil.
The work of Corbin and colleagues
opens the way to dissecting the mecha-
nisms behind calprotectin’s activity and
brings a new appreciation of the healing
power of pus. Moreover, the sequestra-
tion of manganese as a means of limiting
bacterial growth could have broader ap-
plications in controlling bacteria on both
biological and nonbiological surfaces.
This paper opens up many new avenues
of speculation and experimentation!
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